Vitro Diagnostic Usein Europe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SOPHiA GENETICS Advances Blood Cancer Genomic Testing With New Myeloid Solutions
Targets DNA variants and RNA fusion genes for blood cancers, including challenging variants CALR, CEBPA, ASXL1, FLT3
News provided by
Share this article
BOSTON and LAUSANNE, Switzerland, June 1, 2021 /PRNewswire/  
SOPHiA GENETICS, the creator of a global data-sharing network that advances data-driven medicine, today released SOPHiA DDM™ for Blood Cancers, novel blood cancer testing solutions across the entire workflow from setup, genomic testing, and in-house advanced analytics. The solutions target the most relevant DNA variants and RNA fusion genes for blood cancers, and come with SOPHiA DDM™ platform analysis, easing the identification of major biomarkers with secondary and tertiary analyses. ....

United States , Research Use , Smartest Companies Sophi , Blood Cancers , Solution Plus , Myeloid Solution , Vitro Diagnostic Usein Europe , Sophia Genetics , ஒன்றுபட்டது மாநிலங்களில் , ஆராய்ச்சி பயன்பாடு , இரத்தம் புற்றுநோய்கள் , தீர்வு ப்லஸ் , சோபியா ஜெநெடிக்ஸ் ,